Search

Your search keyword '"Chiò, Adriano"' showing total 349 results

Search Constraints

Start Over You searched for: Author "Chiò, Adriano" Remove constraint Author: "Chiò, Adriano" Search Limiters Full Text Remove constraint Search Limiters: Full Text
349 results on '"Chiò, Adriano"'

Search Results

1. Exploring the Impact of Environmental Pollutants on Multiple Sclerosis Progression

2. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

3. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

4. Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

5. Artificial intelligence and statistical methods for stratification and prediction of progression in amyotrophic lateral sclerosis: A systematic review

6. The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases

8. Use of the combination of spirometry, arterial blood gas analysis and overnight oximetry to predict the outcomes of patients affected by motor neuron disease: The Milan‐Torin respiratory score (Mi‐To‐RS)

9. Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study

11. Lithium carbonate in amyotrophic lateral sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A: protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trial

13. Distinct neural signatures of pulvinar in C9orf72 amyotrophic lateral sclerosis mutation carriers and noncarriers

14. European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERNEURO‐NMD)

15. Calculated Maximal Volume Ventilation (cMVV) as a Marker of Early Respiratory Failure in Amyotrophic Lateral Sclerosis (ALS)

16. Resting‐state fMRI functional connectome of C9orf72 mutation status

17. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

18. A mother and her daughter carrying a pathogenic expansion of the HTT gene with a phenotype encompassing motor neuron disease and Huntington's disease.

19. Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis

20. A Genome-Wide Association Study of Myasthenia Gravis

22. No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis

24. The role of peripheral immunity in ALS: a population‐based study

25. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

26. Serum chloride as a respiratory failure marker in amyotrophic lateral sclerosis

28. Spinal cord hypermetabolism extends to skeletal muscle in amyotrophic lateral sclerosis: a computational approach to [18F]-fluorodeoxyglucose PET/CT images

29. Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS

30. Plasma CHI3L1 in Amyotrophic Lateral Sclerosis: A Potential Differential Diagnostic Biomarker

31. Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving reldesemtiv or placebo in FORTITUDE-ALS

32. SOMAscan Proteomics Identifies Novel Plasma Proteins in Amyotrophic Lateral Sclerosis Patients

33. Unexpected frequency of the pathogenic AR CAG repeat expansion in the general population

35. Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosis

37. Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial)

38. Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study

39. The HFE p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with SOD1 Mutations

41. Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS

42. Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study

44. Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis

46. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

47. Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia

50. Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte–colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial

Catalog

Books, media, physical & digital resources